Surat Steps Up as a Startup Hub

Get ready, entrepreneurs! The 21BY72 Startup Summit, organized by IVY Growth Associates, will take place on June 15th and 16th in Surat, India. This big event intends to firmly establish Surat’s position on the global startup map. The conference will feature high-profile attendees, including Gujarat BJP President and Union Minister CR Patil as the chief guest and Gujarat Home Minister Harsh Sanghavi as the guest of honor. Renowned business leaders such as Anupam Mittal (creator of shaadi.com) and Apurva Chamaria (Head of Venture Capital at Google India) will be there to provide useful insights to prospective entrepreneurs.

A Platform for Growth

This summit provides a unique opportunity for startups. Over 20,000 attendees are expected, including 300+ startup founders, 600+ investors, and 100+ venture capital firms. The event will feature:

  • Trailblazers Mine: A live pitching event where selected startups can showcase their ideas to potential investors and industry leaders.
  • Exhibits: Nearly 100 startups will exhibit their innovative products and services, connecting with potential investors and partners.
  • Panel Discussions, Keynotes, and Workshops: Gain valuable knowledge and network with industry experts through interactive sessions.

IVY Growth’s Mission

IVY Growth Associates is dedicated to fostering a thriving startup ecosystem in Surat. By hosting the 21BY72 Summit, they aim to:

  • Connect startups with investors from across the globe (India, UAE, UK, and US).
  • Drive angel investment in India.
  • Accelerate entrepreneurship and boost the local economy.

IVY Growth’s Track Record

In just three years, IVY Growth Associates has made a significant impact. They have:

  • Invested in over 100 startups across various sectors.
  • Launched Arigato Capital, a fund to raise Rs. 250 crores for further investment in promising startups.
  • Built a global network connecting startups with angel investors, particularly focusing on the Middle East, US, and Europe.

Focus on Diverse Sectors

The 21BY72 Startup Summit isn’t all about big names and showy pitches. It aspires to create a well-rounded startup environment in Surat. The event will include entrepreneurs from a variety of industries, including renewable energy, sustainable agriculture (protective farming), education technology (EdTech), and direct-to-consumer (D2C) companies. This diversity reflects the broad range of opportunities available for entrepreneurs in today’s dynamic market. Additionally, IVY Growth Associates has expressed interest in supporting future ventures in FinTech, Agritech (a broader term encompassing sustainable agriculture), Cleantech (technologies that address environmental issues), Software-as-a-Service (SaaS), and Electric Vehicles (EV). By fostering innovation across these sectors, the summit can empower startups to tackle critical challenges and contribute to a more sustainable future.

Long-Term Vision

The 21BY72 Startup Summit is more than a two-day conference. It represents a long-term strategy for Surat’s economic development. IVY Growth Associates’ dedication to establishing a worldwide corridor for angel investors and entrepreneurs demonstrates their confidence in Surat’s potential as a successful startup cluster. By connecting local entrepreneurs with international investment prospects, the summit can help to stimulate the growth of innovative businesses and create high-skilled jobs in the city. This not only benefits individual entrepreneurs, but also boosts Surat’s general economic growth and global renown. The success of the 21BY72 Summit has the potential to pave the road for a more prosperous future for Surat’s startup environment.

Read more: Marketing NewsAdvertising News, PR and Finance NewsDigital News

Share:

editor

Saiba Verma, an accomplished editor with a focus on finance and market trends, contributes to Atom News with a dedication to providing insightful and accurate business news. Saiba Verma analytical approach adds depth to our coverage, keeping our audience well-informed.